Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
about
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesPLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral SpreadLymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic characterRoutes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis.Synthesis and characterisation of self-assembled and self-adjuvanting asymmetric multi-epitope lipopeptides of ovalbumin.Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal modelNanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularizationControl of polymeric nanoparticle size to improve therapeutic delivery.Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agentDevelopment of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.Particle platforms for cancer immunotherapy.Guiding principles in the design of ligand-targeted nanomedicines.Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.Guiding principles in the design of molecular bioconjugates for vaccine applications.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Synthetic nanovaccines for immunotherapy.A brief perspective on the diverging theories of lymphatic targeting with colloids.Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles.In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.Modulating the immune system through nanotechnology.Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.Examination and optimization of the self-assembly of biocompatible, polymeric nanoparticles by high-throughput nanoprecipitation
P2860
Q27306995-564301CC-D753-452B-B6FB-99F4F3362ACEQ28542696-D197B202-0337-4DC6-9672-21E8994740AEQ28608610-14E546F2-F9FC-4789-8E72-F649E7EB3E84Q34995612-4F4067AD-C862-422D-B3B5-9A5A216C368FQ35032669-19845D88-3B6B-4AD1-BAF3-A799A0CEBF72Q35423378-AE9A11EB-13DC-4C18-A4B7-ABD73E4F2E22Q35646297-8C044DE4-8805-4B38-9E40-8A719796412EQ35785838-0C93EE00-9304-4B76-9666-3B8A33F4EF55Q36009031-E5C67643-42A2-44DD-84A4-8D6AC69244EAQ36307555-B844F73D-BD06-4210-85B1-2C5D47AC74F4Q36521096-7CAEF06C-F239-4D6B-AB4A-B9CF82AA7331Q37066550-73694EF9-2E5F-4349-AE56-53FBF82F70ACQ37327825-905DD9E3-157C-4871-ADF8-7931748EC3E8Q37588454-E21A4568-FE8F-4EB0-A6CB-7DB39748E4EEQ38114060-B2F856A5-4A54-4EA3-B16C-4AEA2DC53862Q38189490-91F6426B-D2B5-4CD4-A462-9C58B70DE90FQ38242314-B106144F-9FEA-4B3F-A780-5D75DD28EECBQ38395963-43F104CF-6C4A-4851-8EE5-B52884AB3AC7Q38406190-9CF07470-A57C-4F3D-9A8F-215DE7E53FF5Q40280801-73B6DAD5-2F2A-4BBB-A32A-265BEE6A8B1BQ42578612-13A302D7-ADA9-411F-9260-11816F4EB677Q42740833-1628DBB2-1503-4A35-8C26-C35C4AE4F106Q47111251-0DB6D06D-1C85-4F86-B1A8-7DF05CF14875Q47940254-D4B64152-5172-4A2B-9F5F-17438C68E85CQ48008689-D1289A76-3B62-4CB3-B504-4B9F2FC5078EQ48630939-28196239-AA8F-46FF-B568-9AF4D6F38E13Q51824391-24F312EB-04EA-4666-8BC3-791E6F787D8AQ52148832-A47E5B3A-3E21-4128-9873-529919C1D20EQ55162750-095EA8DB-C20C-401C-BAFC-7769A51B0A26Q58385603-A155A948-6448-4E5E-822E-18C748FFAA6E
P2860
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@ast
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@en
type
label
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@ast
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@en
prefLabel
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@ast
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@en
P2093
P2860
P921
P356
P1476
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.
@en
P2093
Adam W G Alani
Deepa A Rao
Glen S Kwon
Joseph R Robinson
M Laird Forrest
P2860
P304
P356
10.1002/JPS.21970
P407
P577
2010-04-01T00:00:00Z